Search
Omicron prompted spike in COVID cases in pregnant women, but fewer hospitalizations: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/omicron-pregnant-women.html
Women who were pregnant during the recent Omicron surge were diagnosed with COVID-19 at a much higher rate than during previous phases of the pandemic, but were less likely to develop severe illness, a study by UT Southwestern and Parkland Health scientists found.
Dallas researchers seeking senior participants for breathing study: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/breathing-study.html
The National Institutes of Health (NIH) and the National Institute on Aging recently approved funding for a 2022 study by the Institute for Exercise and Environmental Medicine (IEEM).
Brain wave readings may be key to detecting concussions: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-detecting-concussions.html
Measuring levels of a specific brain wave could lead to more objective, definitive methods of diagnosing concussions.
UTSW researchers examine impact of pandemic on children’s mental health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-impact-of-pandemic.html
New research from pediatricians at UT Southwestern and Children's Health reveals the impact of COVID-19 on mental health in children.
UTSW sleep researcher awarded prestigious Breakthrough Prize: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-breakthrough-prize.html
UT Southwestern sleep researcher Masashi Yanagisawa, M.D., Ph.D., has been awarded the Breakthrough Prize in Life Sciences for his discovery of the cause of narcolepsy.
UTSW researchers identify key complex for ribosome generation: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/ribosome-generation.html
UT Southwestern researchers have identified a four-protein complex that appears to play a key role in generating ribosomes – organelles that serve as protein factories for cells – as well as a surprising part in neurodevelopmental disorders.
UT Southwestern honored for Fulbright student involvement: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/fulbright-student-involvement.html
UT Southwestern Medical Center is among the Top Producing Institutions of 2021-2022 Fulbright Students in the U.S., and one of the top producers of U.S. Fulbright students among 4-year, special-focus institutions.
Breaking the shield that protects pancreatic cancer from immunotherapy: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/pancreatic-cancer-immunotherapy.html
Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study led by UT Southwestern researchers suggests.
UTSW geneticist Jonathan Cohen elected to the National Academy of Sciences: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/nas-cohen.html
The National Academy of Sciences (NAS) today elected UT Southwestern scientist Jonathan Cohen, Ph.D., into its membership, one of the highest honors for American scientists, Dr. Cohen, Professor of Internal Medicine in the Center for Human Nutrition and the Eugene McDermott Center for Human Growth
Simmons Cancer Center’s Dr. John Sweetenham to chair National Comprehensive Cancer Network Board of Directors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/sweetenham-nccn.html
John Sweetenham, M.D., Associate Director for Clinical Affairs at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, has been elected Chair of the Board of Directors of the National Comprehensive Cancer Network (NCCN).